Steven S. Pullen - Concepedia

Concepedia

Author

Steven S. Pullen

Boehringer Ingelheim (United States)

Also Known As

Carine M. Boustany, S S Pullen, S. Pullen, Steven, S.S. PULLEN, S.S. Pullen, Steven Pullen, Steven S Pullen, Steven S. Pullen, Steven S. Pullen

60

Publications

3.3K

Citations

27

H-Index

92

Concepts

All Affiliations

Boehringer Ingelheim (United States)University of Pennsylvania Boehringer Ingelheim (Germany)Duke University Sanford Burnham Prebys Medical Discovery Institute

SS

About

Steven S. Pullen is an author at Boehringer Ingelheim (United States) specializing in medicine, natural sciences, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	25	2.3K
2	Natural Sciences	12	12	800
3	Biochemistry	7	7	214
4	Health Sciences	2	2	47
5	Engineering	1	1	42

Steven S. Pullen

×

37

Publications

3.3K

Citations

27

H-Index

	Year	Citations
Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice Pazit Beckerman, Jing Bi‐Karchin, Ae Seo Deok Park, Nature Medicine UrologyRenal FunctionMedicineKidney FailureImmunology	2017	341
CD40−Tumor Necrosis Factor Receptor-Associated Factor (TRAF) Interactions: Regulation of CD40 Signaling through Multiple TRAF Binding Sites and TRAF Hetero-Oligomerization Steven S. Pullen, Heather G. Miller, Daniel S. Everdeen, Biochemistry InflammationSignal TransductionMedicineCd40 SignalingImmune Regulation	1998	246
Renal compartment–specific genetic variation analyses identify new pathways in chronic kidney disease Chengxiang Qiu, Shizheng Huang, Jihwan Park, Nature Medicine GlomerulonephritisUrologyRenal DiseaseMedicineGenetics	2018	231
Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients Denis Delić, Claudia Eisele, Ramona Schmid, PLoS ONE PathologyExtracellular MicrovesiclesType Ii DiabetesMirna SpeciesRenal Function	2016	226
Crystallographic analysis of CD40 recognition and signaling by human TRAF2 Sarah M. McWhirter, Steven S. Pullen, James M. Holton, Proceedings of the National Academy of Sciences	1999	196
CD40 Signaling through Tumor Necrosis Factor Receptor-associated Factors (TRAFs) Steven S. Pullen, Thu Thi Dang, James J. Crute, Journal of Biological Chemistry	1999	185
Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments Xin Sheng, Yuting Guan, Ziyuan Ma, Nature Genetics Allelic VariantKidney TransplantMedicineGeneticsHuman Traits	2021	154
High-Affinity Interactions of Tumor Necrosis Factor Receptor-Associated Factors (TRAFs) and CD40 Require TRAF Trimerization and CD40 Multimerization Steven S. Pullen, Mark E. Labadia, Richard H. Ingraham, Biochemistry ImmunologyMolecular BiologyImmunologic MechanismChemical BiologyInflammation	1999	148
The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells Cory L. Ahonen, Eric M. Manning, Loren D. Erickson, Nature Immunology Signal TransductionCell RegulationCell InteractionImmunologyImmunologic Mechanism	2002	147
In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease Brian L. Lin, Damian Matera, Julia F. Doerner, Proceedings of the National Academy of Sciences	2019	143

Page 1